MALAT1 and gastric cancer: Recent studies have shown that MALAT1 enhances the expression of serine-rich arginine splicing factor 1 (SRSF1) and activates the mammalian rapamycin target (mTOR) signaling pathway to promote the formation of gastric cancer (GC) and hepatocellular carcinoma (HCC) [13,14].